Phase 3
Completed N=119
Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis
Source: ClinicalTrials.gov NCT02618759 ↗Enrolled (actual)
119
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcomePrimary: Number of Patients in Each Treatment That Have Clinical Success Based on IGA at Day 28 ± 2 — 10; 3 Participants — p=0.0745
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The purpose of this study is to evaluate the therapeutic efficacy and safety of DSXS compared to a Placebo (vehicle) in patients with mild to moderate plaque psoriasis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients in Each Treatment That Have Clinical Success Based on IGA at Day 28 ± 2 |
10; 3 | 0.0745 |
| PRIMARY Number of Patients in Each Treatment That Have Treatment Success Based on TLSS at Day 28 ± 2 |
8; 4 | 0.2310 |
| SECONDARY Number of Patients in Each Treatment That Have Clinical Success Based on IGA at Day 28 ± 2 (Patients With a Baseline IGA Score of 3) |
8; 3 | 0.1059 |
| SECONDARY Number of Patients in Each Treatment That Have Treatment Success Based on TLSS at Day 28 ± 2 (Patients With a Baseline IGA Score of 3) |
4; 3 | 0.6962 |
| SECONDARY Number of Patients in Each Treatment That Have Clinical Success Based on IGA at Day 28 ± 2 (Patients With a Baseline IGA Score of 2) |
2; 0 | 1.0000 |
| SECONDARY Number of Patients in Each Treatment That Have Treatment Success Based on TLSS at Day 28 ± 2 (Patients With a Baseline IGA Score of 2) |
16; 10 | 0.1044 |
Eligibility Criteria
Inclusion Criteria
- male and non-pregnant females, 12 years of age or older, with a confirmed diagnosis of mild to moderate plaque psoriasis
Exclusion Criteria
- patient is< 12 years old.
Data sourced from ClinicalTrials.gov (NCT02618759). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.